<Sentences><Sentence date="20150418" id="WSJBLAH_1" sentence="True" source="WSJ"><Text>A licensing company representing the University of Pennsylvania added Johnson &amp; Johnson to its lawsuit challenging a university faculty member over rights to Retin-A acne medicine.</Text><Parse>( (S 
    (NP-SBJ 
      (NP (DT A) (NN licensing) (NN company) )
      (VP (VBG representing) 
        (NP 
          (NP (DT the) (NNP University) )
          (PP (IN of) 
            (NP (NNP Pennsylvania) )))))
    (VP (VBD added) 
      (NP (NNP Johnson) (CC &amp;) (NNP Johnson) )
      (PP-CLR (TO to) 
        (NP 
          (NP (PRP$ its) (NN lawsuit) )
          (VP (VBG challenging) 
            (NP (DT a) (NN university) (NN faculty) (NN member) )
            (PP (IN over) 
              (NP 
                (NP (NNS rights) )
                (PP (TO to) 
                  (NP (NNP Retin-A) (NN acne) (NN medicine) ))))))))
    (. .) ))</Parse></Sentence><Sentence date="20150418" id="WSJBLAH_1" sentence="True" source="WSJ"><Text>University Patents Inc., based in Westport, Conn., said it seeks Johnson &amp; Johnson's profits from sales of Retin-A, estimated at $50 million, a similar amount of punitive damages and the right to license Retin-A elsewhere.</Text><Parse>( (S 
    (NP-SBJ 
      (NP (NNP University) (NNP Patents) (NNP Inc.) )
      (, ,) 
      (VP (VBN based) 
        (NP (-NONE- *) )
        (PP-LOC-CLR (IN in) 
          (NP 
            (NP (NNP Westport) )
            (, ,) 
            (NP (NNP Conn.) )
            (, ,) ))))
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP it) )
          (VP (VBZ seeks) 
            (NP 
              (NP 
                (NP 
                  (NP 
                    (NP (NNP Johnson) (CC &amp;) (NNP Johnson) (POS 's) )
                    (NNS profits) )
                  (PP (IN from) 
                    (NP 
                      (NP (NNS sales) )
                      (PP (IN of) 
                        (NP (NNP Retin-A) )))))
                (, ,) 
                (VP (VBN estimated) 
                  (NP (-NONE- *) )
                  (PP-CLR (IN at) 
                    (NP 
                      (QP ($ $) (CD 50) (CD million) )
                      (-NONE- *U*) ))))
              (, ,) 
              (NP 
                (NP (DT a) (JJ similar) (NN amount) )
                (PP (IN of) 
                  (NP (JJ punitive) (NNS damages) )))
              (CC and) 
              (NP (DT the) (NN right) 
                (S 
                  (NP-SBJ (-NONE- *) )
                  (VP (TO to) 
                    (VP (VB license) 
                      (NP (NNP Retin-A) )
                      (ADVP-LOC (RB elsewhere) ))))))))))
    (. .) ))</Parse></Sentence><Sentence date="20150418" id="WSJBLAH_1" sentence="True" source="WSJ"><Text>In May, University Patents filed a suit in federal court in Philadelphia against Albert M. Kligman, a researcher and professor at the University of Pennsylvania School of Medicine who developed Retin-A in the 1960s to combat acne.</Text><Parse>( (S 
    (PP-TMP (IN In) 
      (NP (NNP May) ))
    (, ,) 
    (NP-SBJ (NNP University) (NNP Patents) )
    (VP (VBD filed) 
      (NP 
        (NP (DT a) (NN suit) )
        (PP (-NONE- *ICH*-1) ))
      (PP-LOC (IN in) 
        (NP (JJ federal) (NN court) ))
      (PP-LOC (IN in) 
        (NP (NNP Philadelphia) ))
      (PP-1 (IN against) 
        (NP 
          (NP (NNP Albert) (NNP M.) (NNP Kligman) )
          (, ,) 
          (NP 
            (NP (DT a) (NN researcher) 
              (CC and)
              (NN professor) )
            (PP-LOC (IN at) 
              (NP 
                (NP (DT the) 
                  (NAC (NNP University) 
                    (PP (IN of) 
                      (NP (NNP Pennsylvania) )))
                  (NNP School) )
                (PP (IN of) 
                  (NP (NNP Medicine) ))))
            (SBAR 
              (WHNP-182 (WP who) )
              (S 
                (NP-SBJ-2 (-NONE- *T*-182) )
                (VP (VBD developed) 
                  (NP (NNP Retin-A) )
                  (PP-TMP (IN in) 
                    (NP (DT the) (CD 1960s) ))
                  (S-PRP 
                    (NP-SBJ (-NONE- *-2) )
                    (VP (TO to) 
                      (VP (VB combat) 
                        (NP (NN acne) )))))))))))
    (. .) ))</Parse></Sentence><Sentence date="20150418" id="WSJBLAH_1" sentence="True" source="WSJ"><Text>Dr. Kligman patented the medicine while employed by the University, but later licensed the Retin-A to a division of Johnson &amp; Johnson.</Text><Parse>( (S 
    (NP-SBJ-1 (NNP Dr.) (NNP Kligman) )
    (VP 
      (VP (VBD patented) 
        (NP (DT the) (NN medicine) )
        (SBAR-TMP (IN while) 
          (S 
            (NP-SBJ-2 (-NONE- *-1) )
            (VP (VBN employed) 
              (NP (-NONE- *-2) )
              (PP (IN by) 
                (NP-LGS (DT the) (NNP University) ))))))
      (, ,) (CC but) 
      (VP 
        (ADVP-TMP (JJ later) )
        (VBD licensed) 
        (NP (DT the) (NNP Retin-A) )
        (PP-CLR (TO to) 
          (NP 
            (NP (DT a) (NN division) )
            (PP (IN of) 
              (NP (NNP Johnson) (CC &amp;) (NNP Johnson) ))))))
    (. .) ))</Parse></Sentence><Sentence date="20150418" id="WSJBLAH_1" sentence="True" source="WSJ"><Text>In New Brunswick, N.J., a Johnson &amp; Johnson spokesman declined comment.</Text><Parse>( (S 
    (PP-LOC (IN In) 
      (NP 
        (NP (NNP New) (NNP Brunswick) )
        (, ,) 
        (NP (NNP N.J.) )
        (, ,) ))
    (NP-SBJ (DT a) (NNP Johnson) (CC &amp;) (NNP Johnson) (NN spokesman) )
    (VP (VBD declined) 
      (NP (NN comment) ))</Parse></Sentence></Sentences>